Clinicians from the five Nordic countries (Norway, Sweden, Finland, Denmark and Iceland) have shared their experience in the management of generalised autoimmune myasthenia with autoantibodies against the acetylcholine receptor, and issued recommendations:
- symptomatic treatment with pyridostigmine (or equivalent) remains the basis of management,
- the role of corticosteroid therapy, traditional immunosuppressants and new molecules such as efgartigimod are also discussed,
- thymectomy may also be useful, whether or not a thymoma has been identified.
The authors stress the importance of comprehensive management and regular support.
